{"id":32427,"date":"2023-03-16T07:00:09","date_gmt":"2023-03-16T05:00:09","guid":{"rendered":"https:\/\/www.ipsen.com\/qa-us\/?post_type=press_release&p=32427"},"modified":"2023-06-26T10:49:56","modified_gmt":"2023-06-26T08:49:56","slug":"ipsen-receives-new-fda-pdufa-date-for-investigational-palovarotene-for-the-treatment-of-people-with-fop","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/us\/press-releases\/ipsen-receives-new-fda-pdufa-date-for-investigational-palovarotene-for-the-treatment-of-people-with-fop\/","title":{"rendered":"Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP"},"content":{"rendered":"\n